The Federal Laboratory Consortium for Technology Transfer (FLC) is honoring 32 FLC Award winners (three of whom are from NIH) from 8 federal agencies for their contributions to technology transfer, which turns cutting-edge research into impactful products and services.

The FLC represents over 300 federal laboratories, agencies and research centers nationwide. Through education, promotion and the facilitation of relationships and partnerships, the FLC supports this tech transfer community to shepherd technologies out of government labs and into the marketplace, where they improve the economy, society and national security. 

This year’s winners represent government-led projects focused on a range of technologies, from agriculture to defense. Award recipients will be honored in person at the 2024 FLC Awards Ceremony and Banquet, held during the FLC National Meeting, April 9-11, 2024, at the Sheraton Dallas Hotel in Dallas, Texas. Adding to the celebration, this year marks the 50th anniversary of the FLC. The media are welcome to attend. 

"Technology transfer benefits our nation and improves our daily lives in many areas. Each year, our judges go through a very competitive process to select only a few to be recognized at our annual Awards Ceremony,” said Paul Zielinski, Executive Director of the FLC. “These award winners exemplify the very best in technology transfer and are deserving of this prestigious honor.”

The NIH has received three FLC awards this year:

TECHNOLOGY TRANSFER INNOVATION AWARD: Recognizes the successful use of innovative or unconventional approaches, such as in-house competitions, to significantly increase the lab’s technology transfer partnerships and results.

National Institutes of Health, Office of Technology Transfer, New Enterprise Technology Transfer System Revolutionizes Tech Transfer at NIH

EXCELLENCE IN TECHNOLOGY TRANSFER AWARD: Honors outstanding work by federal labs in collaborating with industry, academia or other labs to bring technologies from the lab to the marketplace.

National Institute of Allergy and Infectious Diseases (NIAID), Changing Lives in PASLI/APDS Patients, Disease Discovery and Treatment

IMPACT AWARD: Honors federal labs whose technology commercialization efforts have made a tangible and lasting impact on society or the marketplace.

National Institute of Allergy and Infectious Diseases (NIAID), FDA-Approved RSV Vaccine Based on NIAID’s Prefusion F Protein Technology